300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Venture Capital
Web3
Cannabis
LGBT
Celebrity
Climate
Fashion
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Social
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Beauty
Franchise
Mobile Advertising
Non Profit
Internet
Android
Infrastructure
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Canada
United Kingdom
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Sinclair Dunlop

Founder and Managing Partner @ Masa Life Science Fund

Edinburgh, United Kingdom

Sinclair Dunlop is a Series A investor at Masa Life Science Fund in Edinburgh focused on Health Care and Therapeutics. Mr. Dunlop has twenty years of experience successfully partnering new technologies with and delivering competitive returns to international investors. Prior to co-founding Rock Spring Ventures, Mr. Dunlop successfully raised MASA Life Science Ventures, LP (“MLSV” – www.mlsvfund.com). MLSV’s investors include several leading institutions andcorporations in Japan and Korea, including a ‘top-ten’ Japanese Pharmaceutical company, the largest distributor of cardiac-health medical devices in Japan, a global financial institution and one of Japan’s leading publicly-traded Biotechnology companies. Mr. Dunlop’s international network of blue-chip co-investors, his experienced management team and a Scientific Advisory Board of renowned experts successfully built and managed a portfolio of leading life science companies. As Managing Partner of MLSV, he currently serves on the Board of Directors of Maxcyte Inc. and Apellis Pharmaceuticals Inc. He holds an M.B.A. from Columbia Business School, an M.A. (Honours) in Political Economy from Glasgow University, and a M.A. in International Relations from Syracuse University.

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Sinclair Dunlop invests in

Health CareTherapeuticsBiotechnology

Stages Sinclair Dunlop invests in

Series ASeries B

Countries Sinclair Dunlop invests in

United States

Investment Focus

Industry

  • Health Care 1 (50%)
  • Therapeutics 1 (50%)
  • Biotechnology 1 (50%)

Stage

  • Series A 1 (50%)
  • Series B 1 (50%)

Investments

CompanyDescriptionRoundLinks
MediQuest Therapeutics MediQuest Therapeutics
MediQuest is a specialty pharmaceutical / biotechnology company specializing in first in class and best in class topical drug delivery systems. Primary focus is on the discovery, development, and commercialization of products for the topical treatment of inflammatory and infectious diseases. $23M / Series B / Jun 16, 2009
MediQuest Therapeutics MediQuest Therapeutics
MediQuest is a specialty pharmaceutical / biotechnology company specializing in first in class and best in class topical drug delivery systems. Primary focus is on the discovery, development, and commercialization of products for the topical treatment of inflammatory and infectious diseases. $16M / Series A / Jun 15, 2006

Co-Investors

Masa Life Science Fund

About Masa Life Science Fund

VC Fund · Washington, United States

Masa Life Science Fund is a venture capital fund focused on investments in private, high-growth biotechnology, and life sciences companies.

Masa Life Science Fund Contacts

NameEmailPhoneSocials
Sinclair Dunlop Founder and Managing Partner

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Venture Capital
Web3
Cannabis
LGBT
Celebrity
Climate
Fashion
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Social
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Beauty
Franchise
Mobile Advertising
Non Profit
Internet
Android
Infrastructure
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Canada
United Kingdom
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Sinclair Dunlop invest in?

Sinclair Dunlop invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Sinclair Dunlop last invest?

The most recent investment recorded for Sinclair Dunlop closed in Jun 2009. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Sinclair Dunlop Find email